Traws Pharma Inc. (TRAW)
NASDAQ: TRAW
· Real-Time Price · USD
1.52
-0.10 (-6.17%)
At close: Aug 15, 2025, 2:44 PM
Traws Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 20.55B | 21.49M | -29.92M | -8.47M | -123.14M | -4.98M | -4.18M | -4.74M | -4.25M | -5.78M | -5.42M | -5.4M | -4.02M | -4.12M | -3.76M | -3.45M | -4.23M | -4.71M |
Depreciation & Amortization | 2M | 1K | 2K | 2K | 4K | 4K | 4K | 5K | 4K | 3K | 4K | 3K | 4K | 3K | 4K | 3K | 4K | 3K |
Stock-Based Compensation | 265.84M | 161K | 334K | 343K | 380K | 333K | 332K | 360K | 273K | 336K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 65K |
Other Working Capital | 82K | -82K | -41K | -541K | -4.16M | -727K | -53K | -1.17M | -692K | -143K | 1.1M | 433K | -315K | -839K | 526K | -235K | -26K | -1.79M |
Other Non-Cash Items | -32.23B | -26.51M | 24.44M | n/a | 117.46M | n/a | 869K | -706K | 106K | -706K | 239K | -446K | 369K | -64K | 1.56M | -92K | -672K | 636K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -869K | 706K | -106K | 706K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 576K | -576K | 1.11M | -3.35M | -4.56M | 222K | -582K | -95K | -517K | 893K | 1.2M | 1.19M | -435K | -473K | -766K | -477K | 287K | -2.64M |
Operating Cash Flow | -11.41B | -5.44M | -4.04M | -11.48M | -9.85M | -4.42M | -4.43M | -4.47M | -4.49M | -4.54M | -3.88M | -3.9M | -4.21M | -4.3M | -4.26M | -4.27M | -4.31M | -6.65M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | -3,648B | n/a | -3.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 3,648B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | -3.65M | n/a | n/a | -14K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.11B | -109K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7K | 497K |
Financial Cash Flow | 3.11B | 13K | 19.98M | n/a | 14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -35K | 19.94M | 7K | 35.64M |
Net Cash Flow | 13.07B | -5.4M | 15.93M | -11.48M | 496K | -4.43M | -4.42M | -4.49M | -4.49M | -4.54M | -3.86M | -3.92M | -4.23M | -4.3M | -4.31M | 15.68M | -4.3M | 28.98M |
Free Cash Flow | -11.41B | -5.44M | -4.04M | -11.48M | -9.85M | -4.42M | -4.43M | -4.48M | -4.49M | -4.54M | -3.88M | -3.9M | -4.21M | -4.3M | -4.26M | -4.27M | -4.31M | -6.65M |